ArticleClinical and translational science2024

In vitro PK/PD modeling of tyrosine kinase inhibitors in non-small cell lung cancer cell lines.

Linda Wanika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.